PPARγ Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 Cells
- 22 February 2002
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 90 (3) , 348-355
- https://doi.org/10.1161/hh0302.105098
Abstract
Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor superfamily that acts as a key player in adipocyte differentiation, glucose metabolism, and macrophage differentiation. Osteopontin (OPN), a component of extracellular matrix, is elevated during neointimal formation in the vessel wall and is synthesized by macrophages in atherosclerotic plaques. In the present study, we investigated the molecular mechanisms regulating OPN gene expression by PPARγ in THP-1 cells, a cell line derived from human monocytic leukemia cells. Northern and Western blot analyses showed that exposure of THP-1 cells to PMA (phorbol 12-myristate 13-acetate) increases OPN mRNA and protein levels in a time-dependent manner. PMA-induced OPN expression was significantly decreased by troglitazone (Tro) and other PPARγ ligands. Transient transfection assays of the human OPN promoter/luciferase construct showed that PPARγ represses OPN promoter activity, and the PPARγ-responsive region within the OPN promoter lies between −1000 and −970 relative to the transcription start site. Site-specific mutation analysis and electrophoretic mobility shift assays indicated that a homeobox-like A/T-rich sequence between −990 and −981, which functions as a binding site for PMA-induced nuclear factors other than PPARγ, mediates the repression of OPN expression by Tro. Furthermore, concatenated A/T-rich sequences conferred the PPARγ responsiveness on the heterologous promoter. Taken together, these data suggest that PPARγ ligand inhibits OPN gene expression through the interference with the binding of nuclear factors to A/T-rich sequence in THP-1 cells.Keywords
This publication has 25 references indexed in Scilit:
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Activation of the Prolactin Gene by Peroxisome Proliferator-activated Receptor-α Appears to Be DNA Binding-independentPublished by Elsevier ,1998
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.Journal of Clinical Investigation, 1996
- A Human Peroxisome‐Proliferator‐Activated Receptor‐γ is Activated by Inducers of Adipogenesis, Including Thiazolidinedione DrugsEuropean Journal of Biochemistry, 1996
- Inhibition of oxidation of low density lipoprotein by troglitazoneAtherosclerosis, 1996
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.Journal of Clinical Investigation, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993